🔴 Teradyne is trading 5% down with no verified company-specific explanation

Teradyne is trading at $250.68, down -5.24%, with no verified Teradyne-specific announcement explaining the November 4 decline.

• Broader markets were higher, so the supplied evidence does not point to a market-wide selloff driving the drop.
• Recent coverage linked the ongoing selloff to investor concern that fourth-quarter revenue guidance implied little sequential growth; that context does not establish November 4’s trigger.
• No reliable volume or activity-level figure was available.